SUMMARY
The relative benefit versus safety of opioid administered into the epidural space has been a source of debate for many years 1 . Morphine is known to circulate in the cerebrospinal fluid (CSF), being detectable in significant concentrations in the cervical segments after lumbar epidural administration 2 , whereas fentanyl does so much less frequently 3 . The hydrophilic opioids show wider CSF distribution and potentially provide better analgesia, whereas the lipophilic opioids show limited CSF spread and thereby reduce the risk of delayed respiratory depression. Further controversy has been added by Ginosar and colleagues 4 who reported that fentanyl works predominantly at a spinal level when administered as a epidural bolus, but at a supraspinal level when administered as an epidural infusion.
Our group has been performing high thoracic epidural analgesia (HTEA) for cardiac surgery since 1997. Our initial experience was with fentanyl 2 µg/ml as an adjunct to 0.2% ropivacaine. In a randomized controlled trial comparing HTEA with patientcontrolled analgesia (PCA) using morphine 5 , this provided excellent analgesia, with very low pain scores with coughing. The use of HTEA resulted in significantly improved pain control, reduced ventilation time, better cooperation with physiotherapy and a lower risk of depression or symptoms of posttraumatic stress syndrome.
Nevertheless, we observed that a number of patients required frequent adjustments to their infusion, and relatively high infusion rates (12-14 ml/h). Not uncommonly, patients experienced a body "patch" not adequately covered by epidural analgesia, and required either increased infusion rates or epidural boluses to achieve adequate analgesia. As an adjunct, epidural morphine may offer greater CSF spread and be effective against pain in areas not covered by the local anaesthetic solution. In 2000, we changed from fentanyl to morphine as an adjunct to ropivacaine 0.2%, to identify whether the excellent analgesia provided by HTEA could be achieved with fewer interventions to the epidural infusion, and whether the incidence of breakthrough pain (pain other than mild) could be reduced. Because cardiac surgery causes a reproducible wound, it serves as an ideal model for testing differences between drug regimens.
Our aim was to audit whether there was a difference between fentanyl and morphine, when added to ropivacaine, for the number of interventions performed by Acute Pain Service (APS) personnel; the incidence of inadequate analgesia; or the incidence of complications such as respiratory depression or nausea.
METHODS
Our initial experience was with ropivacaine 0.2% with fentanyl 2 µg/ml 5, 6 . In 2000 we changed opioid to 0.02 mg/ml morphine, and our perception was that analgesia improved, not in regard to the overall quality of analgesia, but rather with respect to breakthrough pain and the number of interventions required by APS staff. With hospital ethics committee approval we undertook a retrospective audit of 100 consecutive patients, prior to and following the change in technique. All patients had undergone coronary artery bypass graft (CABG) surgery between 1998 and 2002. The surgery was performed by one surgeon, and the epidural inserted predominantly by one anaesthetist. Information was recorded on designated acute pain service and general hospital records. We obtained retrospective data from these records until 36 hours after surgery. We chose this duration to provide complete datasets over three 12 hour periods -the epidurals were removed between 36 and 48 hours following surgery in the morphine group, and 60 and 72 hours in the fentanyl group.
All consecutive patients who had received morphine or fentanyl adjuncts in their epidural infusion were included. Six patients had their epidural removed within 24 hours because it was not effective (two patients) or was accidentally dislodged. These patients were excluded from the study. Each exclusion resulted in the next consecutive patient being included in the study, in order to achieve the same sample size. Paracetamol, indomethacin and tramadol were used as supplemental analgesics if required.
High Thoracic Epidural Analgesia (HTEA)
Epidural catheters were initially inserted on the night prior to surgery at the T1/2 or T2/3 level, but our practice changed over the audit period to insertion on the day of surgery, allowing a minimum of 1 hour between insertion and anticoagulation. No anaesthetic solution was administered until just prior to the induction of anaesthesia, for both groups. Six to 10 ml of 0.5% ropivacaine was administered, and thereafter, ropivacaine 0.2% with either fentanyl 2 µg/ml or morphine 20 µg/ml was infused at a rate of 3-14 ml/h, adjusted to maintain satisfactory analgesia.
Surgery
All patients received arterial grafts constructed from the left internal mammary artery (LIMA) and left radial artery as a Y-graft, and used to graft all coronary territories 7 . The surgical approach for all patients was via median sternotomy and radial artery harvest (no saphenous vein harvest was performed). Fifty-seven per cent of patients received cardiopulmonary bypass, using a membrane oxygenator and 40 µm arterial filter. Perfusion temperature was 35°C with rewarming to 36.5°C prior to removal of the aortic clamp. Myocardial protection was by intermittent anterograde and retrograde blood cardioplegia. The remaining 43% had off-pump coronary artery bypass surgery (OPCAB), with the heart being stabilized using the Octopus III stabilizing device (Medtronic Inc. Minneapolis MN). The change in technique to favour OPCAB was temporally associated with the change in epidural opioid. During this period, OPCAB became the routine approach for our surgical team, and in general the type of surgery and number of grafts performed were not different, nor was the length of operation. All patients were monitored with a pulmonary artery catheter, indwelling radial arterial catheter, and transoesophageal echocardiography (Sonos 2500 or 5500, Phillips Medical Systems, Andover, MA).
Induction of anaesthesia consisted of midazolam 3-5 mg, fentanyl 200 µg, and a target-controlled infusion of propofol set for a blood concentration of 2 µg/ml ("Diprifusor" algorithm, AstraZeneca, North Ryde, Australia), which was ceased after the last skin suture.
Spontaneous ventilation was allowed if respiratory effort was adequate at the end of surgery; otherwise mechanical ventilation was continued during transfer to the intensive care unit (ICU). Postoperative sedation with propofol was administered only if required, and extubation was performed when the patient was awake, cooperative, normothermic (core body temperature >36° C), with pH >7.3 and PaO2 75 mmHg on 40% inspired oxygen.
The primary endpoint was pain intensity. Verbal pain scores (0-10 scale) were recorded hourly onto the APS chart by the attending nurse. We recorded pain scores ≥4 as an event of 'breakthrough' pain. Secondary endpoints were: 1. the average rate of epidural infusion for the 36-hour period 2. rate adjustment, as defined by an increase or decrease, or the need for an epidural bolus 3. respiratory depression (a respiratory rate below 10 breaths/min, as recorded hourly on the APS chart) 4. the degree of sedation, (as measured on a scale of 0 to 10, where 0=alert and orientated, and 10=not possible to rouse) using the worst sedation score in the 36-hour period 5. noradrenaline usage, given by the number of hours required and the peak rate (µg/min) of infusion for the 36-hour period 6. antiemetic usage, given by the number of doses required during the 36-hour period 7. naloxone usage, given by the number of doses used during the 36-hour period.
Statistical analysis
Continuous variables were summarized as group mean±standard error of the mean (SEM). The analysis of continuous variables was by one-way analysis of variance (ANOVA), or Repeated Measures ANOVA (RM-ANOVA) with Greenhouse-Geisser adjustment. Categorical variables were analysed by the Fisher's exact test. Where appropriate, the raw value of P was adjusted using the Ryan-Holm stepdown Bonferroni procedure for multiple analyses within families of endpoints (P8). The software used for continuous variables was SPPS 11 (SPPS Inc. Chicago). Significance was defined as P8<0.05.
RESULTS
Data were collected on 100 patients in each group. There were no in-hospital deaths, perioperative strokes, or any complications attributable to the use of HTEA. The preoperative and intraoperative variables are shown in Table 1 . The two groups were well matched with two significant differences: the New York Heart Association class was greater in the morphine group (2000-2002) having a higher percentage of class III and IV patients than the fentanyl group (1998-2000) (P8=0.004); and more morphine group patients received off-pump (without cardiopulmonary bypass) surgery (P8=0.02), consistent with the timing of our change in practice.
The number of times a patient reported a pain score of greater than 4 out of 10 was higher in the fentanyl group (2.08±0.29) compared with the morphine group (0.77±0.13)(P8<0.001).
Secondary endpoint measurements are shown in Table 2 . The average rate of infusion for the fentanyl group was higher (8.82±0.17 vs 7.52±0.18 ml/h, P8<0.001). The patients receiving fentanyl infusions also required more rate adjustments (3.09±0.24 vs 1.30±0.15, P8<0.001).
The peak dose and duration of noradrenaline use, if required, was lower for the morphine group (peak dose 1.50±0.24 ml/h versus fentanyl group 3.41±0.48 ml/h, P8<0.001: and duration 5.83 ± 1.01h vs fentanyl group 12.67±1.36h, P8<0.001).
Antiemetic usage was lower in the morphine group (0.60±0.91 vs 1.79±1.23, P8=0.001). There were no significant differences in the incidence of respiratory depression, or in sedation scores. A sub-analysis of the morphine group by on-pump or off-pump surgery is shown in Table 3 . There were no significant differences between on and off-pump surgery patients for any endpoints.
DISCUSSION
This audit found that patients receiving morphine 20 µg/ml had fewer episodes of inadequate analgesia, fewer infusion adjustments, required a lower infusion rate, and required less antiemetic medication compared with those receiving fentanyl 2 µg/ml, as adjuncts to HTEA with ropivacaine 0.2%.
The differences observed between the two opioids may result from differences in the degree of absorption of drug into the cerebrospinal fluid (CSF) and the degree of circulation within the CSF. Gourlay and colleagues in separate studies identified that both fentanyl and morphine achieve significant CSF concentrations following a bolus dose administered into the epidural space at the lumbar level 2, 3 , but that measurable CSF levels at the C7-T1 interspace were reliably seen after morphine and uncommon after fentanyl. Ginosar and co-workers 4 concluded that epidural fentanyl acted predominantly via spinal mechanisms when administered as a bolus, but predominantly at supraspinal sites (systemic absorption) when administered as an infusion. It is likely that epidural fentanyl works at both sites 1 , but this issue has not yet been fully evaluated. The differences observed in our study could be ascribed to the greater distribution of morphine within the CSF, compared with fentanyl. Segments not adequately blocked by the local anaesthetic are more likely to be 'covered' by morphine than fentanyl, resulting in fewer episodes of breakthrough pain.
We had previously shown that analgesia from HTEA is excellent, including with coughing 5 . We considered it unlikely that morphine would improve overall pain scores, but rather allow fewer APS interventions, at a lower infusion rate. A reduced infusion rate might confine the sympathectomy, with less potential for hypotension. A recent study by Higuchi and colleagues 8 , however, raises a more serious potential effect of a higher epidural infusion volume. Magnetic resonance imaging (MRI) evaluated the volume change in CSF, and in the CSF velocity waveform (which is an indicator of spinal cord perfusion) after a bolus of epidural saline. Even a small bolus (5 ml) was capable of producing significant decreases in CSF volume, with incremental boluses producing mean change in CSF volume of 50% of the epidural bolus volume. More concerningly, the CSF velocity waveform became abnormal in 50% of patients and did not return to normal for 30 minutes. It is possible that techniques to reduce the number of boluses or infusion rate might be of relevance in reducing the risk of spinal cord ischaemia.
The use of morphine as a sole epidural drug or in conjunction with local anaesthetic is not a new concept, but enthusiasm fell following reports of respiratory depression. It has been shown that the safety profile of epidural morphine is dose-dependent. High doses are associated with a series of reports C. F. Royse, A. G. Royse, D. A. Deelen Pain=incidence of pain ≥4/10 on visual analogue pain scale; Rate=mean rate of epidural infusion (ml/min); Rate adjustment=mean number of adjustments to rate; NA hours= number of hours that noradrenaline was given; NA peak rate= highest rate of noradrenaline infusion (µg/min); Respiratory rate <10=mean rate of respiratory rate <10 breaths/min; Antiemetic=mean number of times antiemetic medication was administered; Naloxone=number of times naloxone was administered; Sedation=the highest 0-10 sedation score. Values are shown as mean±SEM. P statistic is from analysis of variance with repeated measures (RM-ANOVA). P is the statistic adjusted for multiple comparisons using the Ryan-Holm Bonferroni
Stepdown procedure, and calculated if P<0.05. Pain=incidence of pain ≥4/10 on visual analogue pain scale; Rate=mean rate of epidural infusion (ml/min); Rate adjustment=mean number of adjustments to rate; NA hours=number of hours that noradrenaline was given; NA peak rate=highest rate of noradrenaline infusion (µg/min); Respiratory rate <10=mean rate of respiratory rate <10 breaths/ min; Antiemetic=mean number of times antiemetic medication was administered; Naloxone=number of times naloxone was administered; Sedation=the highest 0-10 sedation score. Values are shown as the mean±SEM. P statistic is from analysis of variance with repeated measures (RM-ANOVA). P8 is the statistic adjusted for multiple comparisons using the Ryan-Holm Bonferroni
Stepdown procedure, and calculated if P<0.05.
of respiratory depression [9] [10] [11] [12] [13] , but the safety profile of low-dose morphine appears different. Fuller and co-workers 14 retrospectively reviewed 4880 patients who had received a single 2-5 mg bolus of epidural morphine for analgesia after caesarean section and reported respiratory depression (respiratory rate < 10 breaths/min) in only 0.25% of patients. De LeonCasasola and colleagues 15 investigated continuous low-dose morphine (100 µg/ml morphine with 0.05% or 0.1% bupivacaine at 5-10 ml/h as an adjunct to epidural bupivacaine in 4227 surgical cancer patients. Respiratory depression was observed in only three cases (0.07%). Fischer and co-workers 16 , compared 100 µg/ml morphine and fentanyl 10 µg/ml, with bupivacaine 0.1% at 5 ml/h in postoperative patients and found no events of respiratory depression in 48 patients. Our technique differs in that epidural catheters were in high thoracic interspaces, which might prompt concern that CSF migration of morphine would be more rapid than after lumbar epidural administration. We also used a much lower dose of morphine. Our results, however, support a low incidence of respiratory depression.
Low-dose morphine also reduces side-effects compared with higher dose morphine. Fuller and colleagues 14 found that 40% of patients reported nausea and vomiting after a 2-5 mg bolus of epidural morphine, falling to 22% with continuous low-dose epidural morphine. Only 3% of patients reported by de Leon-Casasola developed hypotension after lowdose epidural morphine 15 . Our fentanyl group had a greater incidence of breakthrough pain requiring intervention, usually by a bolus of the epidural infusion solution, followed by an increase in the rate of infusion. In a small elderly patient, this approach can deliver a 'clinically important' dose of fentanyl (10-20 µg) that might increase the risk of respiratory depression.
The main limitation to our study is that it is a retrospective audit. The data were recorded on our hospital APS chart by a range of nurses, and the conditions of recording were not standardized, reducing the consistency of data compared with prospective collection or a randomized trial. Coronary artery bypass surgery produces a consistent wound and involves a reasonably homogeneous population. The increased severity of illness of patients over the time of the audit was consistent with the trend at our institution for a greater incidence of high-risk patients presenting for surgery. The greater incidence of OPCAB patients in the Morphine group resulted from a change in philosophy within our institution at that time. The surgical incision, however, is the same, and we were unable to find any significant differences between off pump and on pump cohorts, although we urge caution in interpretation of our findings, because of a possible confounding effect from the simultaneous change in analgesia regimen and surgical approach. We have only compared fentanyl 2 µg/ml, and the incidence of breakthrough pain is less with 4 µg /ml 17 , although the risk of hypotension, nausea and pruritus is increased at the higher concentration of fentanyl. After the introduction of morphine, we further observed that acceptable analgesia after cessation of the infusion lasted for most of the day (about 8 hours), whereas analgesia after ceasing fentanyl solutions dissipated in 1-2 hours, often leading to an abrupt increase in pain. These effects allowed reduction of the infusion duration by one day, because we had previously identified that pain is well controlled with oral analgesics after 72 hours 5 . As a consequence, there was a difference between groups in the number of 12 hour periods included in the audit, and for consistency, we included only the first three 12 hour periods in the data collection. We did not present data following removal of the epidural catheter, because our APS charts cease at that point, but the effect of different adjuncts on subsequent analgesia duration is worthy of further investigation.
Our findings suggest morphine 20 µg/ml may be better than fentanyl 2 µg/ml as an adjunct to 0.2% ropivacaine, by reducing the number of interventions required to optimize analgesia and the incidence of inadequate analgesia episodes, despite a lower thoracic epidural infusion rate being required.
